Global Life Science Ventures — Investing in the life sciences

Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than € 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.

Home  Sitemap  Imprint

Investment Practice

identifying market potential —
meeting unmet medical needs —
delivering return on investment

GLSV predominantly focuses on making investments in early-stage companies. Through its close contacts with academic and institutional centres of excellence, GLSV is able to identify companies that have innovative technologies with considerable market potential. In certain cases, GLSV may also decide to invest in later stage companies, including buy-outs, which fulfil its investment criteria.

By building on the foundation of its investment philosophy, GLSV is able to deliver the best possible investment practice to its portfolio companies.